OOIR: Observatory of International Research

Papers

(The TQCC of Clinics in Liver Disease is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Hepatocellular Carcinoma	92
Epidemiology of Hepatic Encephalopathy	46
Evaluation and Management of Esophageal and Gastric Varices in Patients with Cirrhosis	43
The Changing Global Epidemiology of Hepatocellular Carcinoma	40
Diagnosis and Management of Hepatic Encephalopathy	32
Tyrosine Kinase Inhibitors and Hepatocellular Carcinoma	30
Role of Biomarkers and Biopsy in Hepatocellular Carcinoma	25
Noninvasive Detection of Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease	25
Prevention of First Decompensation in Advanced Chronic Liver Disease	24
Acute Decompensation and Acute-on-Chronic Liver Failure	23
Minimal Hepatic Encephalopathy	23
Pathophysiology of Hepatic Encephalopathy	22
Hepatitis B Virus Reactivation	20
Epidemiology of Alcohol-Associated Liver Disease	20
Frailty and Sarcopenia in Patients Pre– and Post–Liver Transplant	18
Hepatocellular Carcinoma	18
Cholangiocarcinoma	17
Current Concepts of Cirrhotic Cardiomyopathy	17
Malnutrition and Alcohol-Associated Hepatitis	16
Surgical Resection	15
The Role of Hepatic Venous Pressure Gradient in the Management of Cirrhosis	15
New Treatments for Chronic Hepatitis B Virus/Hepatitis D Virus Infection	15
Thrombocytopenia in Chronic Liver Disease	15
Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers	14
The Health Care Burden of Hepatic Encephalopathy	13

Endoscopic Treatment of Esophageal Varices	12
Prognosis of Hepatic Encephalopathy	12
Treatment and Prevention of Acute Hepatitis B Virus	12
Pharmacologic Management of Hepatic Encephalopathy	12
Novel Therapies in Hepatic Encephalopathy	12
Cardiac and Pulmonary Vascular Risk Stratification in Liver Transplantation	12
Biliary Atresia in Children	11
Alagille Syndrome	11
Obesity Management of Liver Transplant Waitlist Candidates and Recipients	11
Metabolic Syndrome and Its Association with Nonalcoholic Steatohepatitis	11
Advances in Hepatocellular Carcinoma	11
Focal Nodular Hyperplasia and Hepatic Adenoma	11
Bacterial Infections in Cirrhosis as a Cause or Consequence of Decompensation?	11
Hyponatremia in Cirrhosis	10
Evaluation and Management of Pruritus in Primary Biliary Cholangitis	10
Clinical Manifestations of Hepatic Encephalopathy	10
Overview of Progressive Familial Intrahepatic Cholestasis	10
Moderate Alcoholic Hepatitis	10
Role of External Beam Radiotherapy in Hepatocellular Carcinoma	10
Lifestyle and Environmental Approaches for the Primary Prevention of Hepatocellular Carcinoma	9
Viral Hepatitis Other than A, B, and C	9
Endoscopic Ultrasound-Guided Liver Biopsy	9
Beyond Ice and the Cooler	9
Budd-Chiari Syndrome	9
Management of Side Effects of Systemic Therapies for Hepatocellular Carcinoma	9
Alpha-1 Antitrypsin Deficiency Liver Disease	8
Endoscopic Treatment of Gastric and Ectopic Varices	8
Surveillance for Hepatocellular Carcinoma	8
Immunologic Responses and the Pathophysiology of Primary Biliary Cholangitis	8
Laboratory Abnormalities of Hepatic Encephalopathy	8
Nonalcoholic Fatty Liver Disease: Disease Burden and Disease Awareness	8
Immuno-oncology for Hepatocellular Carcinoma	8
Chronic Hepatitis B Virus and Hepatitis D Virus	7
Expanding Role of Donation After Circulatory Death Donors in Liver Transplantation	7
Coronavirus Disease-2019 and Implications on the Liver	7
Expanding Donor Selection and Recipient Indications for Living Donor Liver Transplantation	7
Long-Term Management	7
The Impact of Allocation Changes on Patients with Hepatocellular Carcinoma	6
Imaging Diagnosis of Hepatocellular Carcinoma	6
Research Priorities for Precision Medicine in NAFLD	6
The Interplay Between Nonalcoholic Fatty Liver Disease and Kidney Disease	6
Hepatorenal Syndrome	6
Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma	6
Emerging Therapies for Alcoholic Hepatitis	6
Wilson Disease in Children	6
Alcohol-Related Liver Disease Including New Developments	6
Polycystic Kidney/Liver Disease	6
Pediatric Liver Transplantation	6
Microbiome	6
Keeping Patients with End-Stage Liver Disease Alive While Awaiting Transplant	5

Mitochondrial Hepatopathy	5
Autoantibodies in Primary Biliary Cholangitis	5
Hepatitis B and C in Children	5
Special Population	5
Interpretation of HBV Serologies	5
Cutaneous Manifestations of Chronic Liver Disease	5
Endoscopic Ultrasound for the Diagnosis and Staging of Biliary Malignancy	5
Controversies in the Management of Hepatitis B	5
Future Treatment Options and Regimens for Nonalcoholic Fatty Liver Disease	5
Hepatitis B and Health Care Workers	5
Economic Burden and Patient-Reported Outcomes of Nonalcoholic Fatty Liver Disease	5
Novel Therapies That May Cure Chronic Hepatitis B Virus	5
Genetic and Environmental Susceptibility to Alcoholic Hepatitis	5
Contemporary Epidemiology of Primary Biliary Cholangitis	5
Treatment of Chronic Hepatitis B Virus with Oral Anti-Viral Therapy	5
Nonpharmacologic Management of Hepatic Encephalopathy	5
Invasive Procedures in Patients with Cirrhosis	5
Nutritional Evaluation and Treatment of the Cirrhotic Patient	5
Nonalcoholic Fatty Liver Disease in Latin America and Australia	5
Treatment of Acute Variceal Bleeding in 2021—When to Use Transjugular Intrahepatic Portosystemic Shunts?	5
Hepatocellular Carcinoma in Primary Biliary Cholangitis	5
An Update on Pediatric Acute Liver Failure	5
Optimizing the Selection of Patients for Simultaneous Liver-Kidney Transplant	5